Molly Henderson - Net Worth and Insider Trading

Molly Henderson Net Worth

The estimated net worth of Molly Henderson is at least $2 Million dollars as of 2024-11-05. Molly Henderson is the CFO and CBO of Phathom Pharmaceuticals Inc and owns about 101,358 shares of Phathom Pharmaceuticals Inc (PHAT) stock worth over $2 Million. Molly Henderson is the CFO of UroGen Pharma Ltd and owns about 5,248 shares of UroGen Pharma Ltd (URGN) stock worth over $63,238. Molly Henderson is also the CBFO of VirtualScopics Inc and owns about 14,400 shares of VirtualScopics Inc (VSCP) stock worth over $58,176. Details can be seen in Molly Henderson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Molly Henderson has not made any transactions after 2024-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Molly Henderson

To

Molly Henderson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Molly Henderson owns 5 companies in total, including UroGen Pharma Ltd (URGN) , Advaxis Inc (ADXS) , and Iovance Biotherapeutics Inc (IOVA) among others .

Click here to see the complete history of Molly Henderson’s form 4 insider trades.

Insider Ownership Summary of Molly Henderson

Ticker Comapny Transaction Date Type of Owner
URGN UroGen Pharma Ltd 2022-01-31 Chief Financial Officer
ADXS Advaxis Inc 2018-06-06 Executive Vice President & CFO
IOVA Iovance Biotherapeutics Inc 2015-06-08 Chief Financial Officer
LIMIT LIMIT 2013-01-29 Chief Business/Financial Off.
LIMIT LIMIT 2024-07-15 CFO and CBO

Molly Henderson Latest Holdings Summary

Molly Henderson currently owns a total of 3 stocks. Among these stocks, Molly Henderson owns 101,358 shares of Phathom Pharmaceuticals Inc (PHAT) as of July 15, 2024, with a value of $2 Million and a weighting of 93.95%. Molly Henderson owns 5,248 shares of UroGen Pharma Ltd (URGN) as of January 31, 2022, with a value of $63,238 and a weighting of 3.15%. Molly Henderson also owns 14,400 shares of VirtualScopics Inc (VSCP) as of June 19, 2012, with a value of $58,176 and a weighting of 2.9%.

Latest Holdings of Molly Henderson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PHAT Phathom Pharmaceuticals Inc 2024-07-15 101,358 18.59 1,884,245
URGN UroGen Pharma Ltd 2022-01-31 5,248 12.05 63,238
VSCP VirtualScopics Inc 2012-06-19 14,400 4.04 58,176

Holding Weightings of Molly Henderson


Molly Henderson Form 4 Trading Tracker

According to the SEC Form 4 filings, Molly Henderson has made a total of 10 transactions in Phathom Pharmaceuticals Inc (PHAT) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Phathom Pharmaceuticals Inc is the sale of 4,325 shares on July 15, 2024, which brought Molly Henderson around $50,689.

According to the SEC Form 4 filings, Molly Henderson has made a total of 3 transactions in UroGen Pharma Ltd (URGN) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in UroGen Pharma Ltd is the sale of 331 shares on January 31, 2022, which brought Molly Henderson around $2,509.

According to the SEC Form 4 filings, Molly Henderson has made a total of 0 transactions in VirtualScopics Inc (VSCP) over the past 5 years. The most-recent trade in VirtualScopics Inc is the acquisition of 8,000 shares on June 19, 2012, which cost Molly Henderson around $7,200.

Insider Trading History of Molly Henderson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Molly Henderson Trading Performance

GuruFocus tracks the stock performance after each of Molly Henderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Molly Henderson is -2.5%. GuruFocus also compares Molly Henderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Molly Henderson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Molly Henderson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Molly Henderson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.3 LIMIT LIMIT LIMIT LIMIT LIMIT

Molly Henderson Ownership Network

Ownership Network List of Molly Henderson

No Data

Ownership Network Relation of Molly Henderson

Insider Network Chart

Molly Henderson Owned Company Details

What does UroGen Pharma Ltd do?

Who are the key executives at UroGen Pharma Ltd?

Molly Henderson is the Chief Financial Officer of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include General Counsel Jason Drew Smith , Chief Medical Officer Mark Schoenberg , and Chief Financial Officer Dong Kim .

UroGen Pharma Ltd (URGN) Insider Trades Summary

Over the past 18 months, Molly Henderson made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 25,590 shares made by Mark Schoenberg , and a net sale of 15,307 shares made by Jason Drew Smith .

In summary, during the past 3 months, insiders sold 2,380 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 2,380 shares. During the past 18 months, 40,897 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,897 shares.

UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

UroGen Pharma Ltd Insider Transactions

No Available Data

Molly Henderson Mailing Address

Above is the net worth, insider trading, and ownership report for Molly Henderson. You might contact Molly Henderson via mailing address: 305 College Road East, Princeton Nj 08540.